Meggiato et al. also found increased IGF-1 serum levels in only 10% of patients with pancreatic cancer, and their analysis showed no differences in IGF-1 according to tumor stage or size [64]. This evidence concerns the gene IGF1 and familial pancreatic carcinoma.